UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 

July 26, 2005
(Date of report)
 

CARACO PHARMACEUTICAL LABORATORIES, LTD.
(Exact name of registrant as specified in its charter)
 
 
Michigan   0-24676   38-2505723
 
 
(State or other jurisdiction   (Commission file number)   (I.R.S. employer
of incorporation)       identification no.)
 
 
1150 Elijah McCoy Drive, Detroit, Michigan 48202
(Address of principal executive offices)
 
(313) 871-8400
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 140.14a-12)
   
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
   
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))

 


Item 2.02.  Results of Operations and Financial Condition
 
                On July 26, 2005, registrant announced its results of operations for the first quarter of its new fiscal year (the quarter ended June 30, 2005), as set forth in the press release included as Exhibit 99.1 hereto, which is incorporated herein by reference.
 
Item 9.01.  Financial Statements and Exhibits
 
c)             Exhibits
 
Exhibit No.           Description
 
99.1         Press Release of Caraco Pharmaceutical Laboratories, Ltd., dated July 26, 2005 announcing its results of operations for its first quarter of fiscal 2006.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
CARACO PHARMACEUTICAL LABORATORIES, LTD.
 
 
 Date:   July 26, 2005  By:   /s/ Daniel H. Movens
   
      Daniel H. Movens
      Chief Executive Officer

 


Exhibit Index

 
99.1
Press Release of Caraco Pharmaceutical Laboratories, Ltd., dated July 26, 2005 announcing its results of operations for its first quarter of fiscal 2006.

2